Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)

References

• ColesAMultiple sclerosisPract Neurol20099211812619289565
   PubMedGoogle Scholar
• SadovnickADEbersGCDymentDARischNJEvidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study GroupLancet19963479017172817308656905
   PubMed Web of Science ®Google Scholar
• SadovnickADEbersGCEpidemiology of multiple sclerosis: a critical overviewCan J Neurol Sci199320117298467424
   PubMed Web of Science ®Google Scholar
• KatrychOSimoneTMAzadSMousaSADisease-modifying agents in the treatment of multiple sclerosis: a review of long-term outcomesCNS Neurol Disord Drug Targets20098651251919811446
   PubMed Web of Science ®Google Scholar
• OliverBJKohliEKasperLHInterferon therapy in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of the comparative trialsJ Neurol Sci20113021–29610521167504
   PubMed Web of Science ®Google Scholar
• DevonshireVArbizuTBorreBPatient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb studyBMC Neurol2010102820433746
   PubMed Web of Science ®Google Scholar
• MenzinJCaonCNicholsCWhiteLAFriedmanMPillMWNarrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosisJ Manag Care Pharm2013191 Suppl AS24S4023383731
   PubMed Web of Science ®Google Scholar
• DorALageMJTarrantsMLCastelli-HaleyJCost sharing, benefit design, and adherence: the case of multiple sclerosisAdv Health Econ Health Serv Res20102217519320575233
   PubMedGoogle Scholar
• WHOAdherence to Long-term Therapies: Evidence for Action2003 Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/Accessed March 1, 2018
   Google Scholar
• CostelloKKennedyPScanzilloJRecognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long termMedscape J Med200810922519008986
   PubMedGoogle Scholar
• ZettlUKBauer-SteinhusenUGlaserTHechenbichlerKLimmrothVEvaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort studyBMC Neurol20131311724011220
   PubMed Web of Science ®Google Scholar
• CramerJACuffelBJDivanVAl-SabbaghAGlassmanMPatient satisfaction with an injection device for multiple sclerosis treatmentActa Neurol Scand2006113315616216441244
   PubMed Web of Science ®Google Scholar
• MikolDLopez-BresnahanMTaraskiewiczSChangPRangnowJA randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosisMult Scler200511558559116193898
   PubMed Web of Science ®Google Scholar
• DevonshireVLapierreYMacdonellRThe Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosisEur J Neurol2011181697720561039
   PubMed Web of Science ®Google Scholar
• TreadawayKCutterGSalterAFactors that influence adherence with disease-modifying therapy in MSJ Neurol2009256456857619444532
   PubMed Web of Science ®Google Scholar
• MohrDCBoudewynACLikoskyWLevineEGoodkinDEInjectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-injectAnn Behav Med200123212513211394554
   PubMed Web of Science ®Google Scholar
• BayasAImproving adherence to injectable disease-modifying drugs in multiple sclerosisExpert Opin Drug Deliv201310328528723339371
   PubMed Web of Science ®Google Scholar
• BayasAOualletJCKallmannBHuppertsRFuldaUMarhardtKAdherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART studyExpert Opin Drug Deliv20151281239125026098143
   PubMed Web of Science ®Google Scholar
• TanHCaiQAgarwalSStephensonJJKamatSImpact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosisAdv Ther2011281516121153000
   PubMed Web of Science ®Google Scholar
• BarberoPVerdunEBerguiMHigh-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction studyJ Neurol Sci20042221–2131915240190
   PubMed Web of Science ®Google Scholar
• RioJPorcelJTellezNFactors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosisMult Scler20051130630915957512
   PubMed Web of Science ®Google Scholar
• TrojanoMRussoPFuianiAThe Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNbeta exposure in multiple sclerosisMult Scler20061257858517086903
   PubMed Web of Science ®Google Scholar
• SaundersCCaonCSmrtkaJShoemakerJFactors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosisJ Neurosci Nurs201042S101821049829
   PubMed Web of Science ®Google Scholar
• LugaresiAAddressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?Expert Opin Drug Deliv20096995100219637982
   PubMed Web of Science ®Google Scholar
• LugaresiAFlorioCBrescia-MorraVPatient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV studyBMC Neurol201212722390218
   PubMed Web of Science ®Google Scholar
• WraySArmstrongRHerrmanCResults from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) studyExpert Opin Drug Deliv201181543155322032264
   PubMed Web of Science ®Google Scholar